Switzerland, home to some the world's most recognisable luxury brands, now faces an upcoming 39 per cent tariff from the US ...

Swiss officials plan to negotiate urgently for a lower rate, before the punishing levy takes effect next week.

In a market note on Wednesday, Scotiabank increased its price target for Apellis Pharmaceuticals, Inc.’s (NASDAQ:APLS) stock ...

On July 31, the Trump administration told 17 major drugmakers to align U.S. medication prices with the lowest prices sold in other countries, or the most-favored-nation price.  The White House ...

Experts are skeptical that Big Pharma companies will cut prices after President Donald Trump demands Most Favored Nation policies within 60 days.

The update was requested by the FDA based on data supporting the significant LDL-C lowering abilities of PCSK-targeting therapies.

Novartis announced the FDA approved updated labeling for inclisiran, a small-interfering RNA therapy, for use as monotherapy ...

Switzerland’s exporters, from watch makers to pharmaceutical companies, are bracing for the financial fallout from Trump’s 39% tariffs.

Simon J. Evenett, professor at IMD Business School in Morges, said the Swiss goods trade surplus surged 56% in 2024, with the U.S. over 2023's total. "The original 31% tariff [threatened by the Trump ...

The Swiss manufacturing sector faces significant challenges as a result of a new 39% U.S. tariff, more than double that of ...

The University of Copenhagen is excited to announce XPRIZE Healthspan as Tier 5 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the ...